179 related articles for article (PubMed ID: 29943725)
1. Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials.
Ebenebe JC; Ntadom G; Ambe J; Wammanda R; Jiya N; Finomo F; Emechebe G; Mokuolu O; Akano K; Agomo C; Folarin OA; Oguche S; Useh F; Oyibo W; Aderoyeje T; Abdulkadir M; Ezeigwe NM; Happi C; Sowunmi A;
Am J Trop Med Hyg; 2018 Sep; 99(3):649-664. PubMed ID: 29943725
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments.
Gbotosho GO; Sowunmi A; Happi CT; Okuboyejo TM
Am J Trop Med Hyg; 2011 Jun; 84(6):936-43. PubMed ID: 21633031
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.
Sowunmi A; Akano K; Ayede AI; Ntadom G; Adewoye EO; Fatunmbi B; Aderoyeje T
Infect Dis Poverty; 2016 Jul; 5(1):70. PubMed ID: 27384596
[TBL] [Abstract][Full Text] [Related]
4. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
[TBL] [Abstract][Full Text] [Related]
5. Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials.
Sowunmi A; Fatunmbi B; Akano K; Wewe OA; Agomo C; Finomo F; Ebenebe J; Jiya N; Ambe J; Wammanda R; Ntadom G; Mokuolu O; Emechebe G; Ezeigwe N; Ayede AI; Adewoye EO; Gbotosho GO; Folarin OA; Happi CT; Oguche S; Oyibo WA; Useh F
BMC Infect Dis; 2017 Dec; 17(1):781. PubMed ID: 29258448
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
7. Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria.
Sowunmi A; Ntadom G; Akano K; Ibironke FO; Ayede AI; Agomo C; Folarin OA; Gbotosho GO; Happi C; Oguche S; Okafor HU; Meremikwu M; Agomo P; Ogala W; Watila I; Mokuolu O; Finomo F; Ebenebe JC; Jiya N; Ambe J; Wammanda R; Emechebe G; Oyibo W; Useh F; Aderoyeje T; Dokunmu TM; Alebiosu OT; Amoo S; Basorun OK; Wewe OA; Okafor C; Akpoborie O; Fatunmbi B; Adewoye EO; Ezeigwe NM; Oduola A
Infect Dis Poverty; 2019 Aug; 8(1):69. PubMed ID: 31383040
[TBL] [Abstract][Full Text] [Related]
8. Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children.
Akano K; Ntadom G; Agomo C; Happi CT; Folarin OA; Gbotosho GO; Mokuolu O; Finomo F; Ebenebe JC; Jiya N; Ambe J; Wammanda R; Emechebe G; Basorun OK; Wewe OA; Amoo S; Ezeigwe N; Oguche S; Fatunmbi B; Sowunmi A
Infect Dis Poverty; 2018 Dec; 7(1):122. PubMed ID: 30522524
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.
Oguche S; Okafor HU; Watila I; Meremikwu M; Agomo P; Ogala W; Agomo C; Ntadom G; Banjo O; Okuboyejo T; Ogunrinde G; Odey F; Aina O; Sofola T; Sowunmi A
Am J Trop Med Hyg; 2014 Nov; 91(5):925-935. PubMed ID: 25246693
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
Onyamboko MA; Fanello CI; Wongsaen K; Tarning J; Cheah PY; Tshefu KA; Dondorp AM; Nosten F; White NJ; Day NP
Antimicrob Agents Chemother; 2014 Sep; 58(9):5528-36. PubMed ID: 25001306
[TBL] [Abstract][Full Text] [Related]
11. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments.
Sowunmi A; Akano K; Ntadom G; Ayede AI; Ibironke FO; Aderoyeje T; Adewoye EO; Fatunmbi B; Oguche S; Okafor HU; Watila I; Meremikwu M; Agomo P; Ogala W; Agomo C; Folarin OA; Gbotosho GO; Happi CT
Infect Dis Poverty; 2017 Feb; 6(1):36. PubMed ID: 28173853
[TBL] [Abstract][Full Text] [Related]
13. Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.
Sowunmi A; Akano K; Ayede AI; Adewoye EO; Ntadom G; Fatunmbi B; Gbotosho GO; Folarin OA; Happi CT
BMC Infect Dis; 2017 Jan; 17(1):110. PubMed ID: 28143417
[TBL] [Abstract][Full Text] [Related]
14. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria.
Sowunmi A; Gbotosho GO; Happi CT; Adedeji AA; Fehintola FA; Folarin OA; Tambo E; Fateye BA
Am J Trop Med Hyg; 2007 Aug; 77(2):235-41. PubMed ID: 17690392
[TBL] [Abstract][Full Text] [Related]
16. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
Nji AM; Ali IM; Moyeh MN; Ngongang EO; Ekollo AM; Chedjou JP; Ndikum VN; Evehe MS; Froeschl G; Heumann C; Mansmann U; Ogundahunsi O; Mbacham WF
Malar J; 2015 Jan; 14():27. PubMed ID: 25626448
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018.
Nhama A; Nhamússua L; Macete E; Bassat Q; Salvador C; Enosse S; Candrinho B; Carvalho E; Nhacolo A; Chidimatembue A; Saifodine A; Zulliger R; Lucchi N; Svigel SS; Moriarty LF; Halsey ES; Mayor A; Aide P
Malar J; 2021 Oct; 20(1):390. PubMed ID: 34600544
[TBL] [Abstract][Full Text] [Related]
18. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
19. Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
Yeka A; Wallender E; Mulebeke R; Kibuuka A; Kigozi R; Bosco A; Kyambadde P; Opigo J; Kalyesubula S; Senzoga J; Vinden J; Conrad M; Rosenthal PJ
J Infect Dis; 2019 Mar; 219(7):1112-1120. PubMed ID: 30418593
[TBL] [Abstract][Full Text] [Related]
20. Oral artesunate-amodiaquine and artemether-lumefantrine in the treatment of uncomplicated hyperparasitaemic Plasmodium falciparum malaria in children.
Gbotosho GO; Sowunmi A; Okuboyejo TM; Happi CT
J Trop Pediatr; 2012 Apr; 58(2):151-3. PubMed ID: 21622538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
